View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
March 17, 2013

China to assist Ghana in finding origin of counterfeit medicine influx

Chinese embassy officials have promised the Ghanaian Food and Drug Authority to help find the origins of a flood of counterfeit drugs in the country that are alleged to have come from China, the Government of Ghana's official website reports.

By Heidi Vella

Ghana

Chinese embassy officials have promised the Ghanaian Food and Drug Authority to help find the origins of a flood of counterfeit drugs in the country that are alleged to have come from China, the Government of Ghana‘s official website reports.

Free Whitepaper
img

What is the impact of China’s Zero-COVID lockdowns on economic activity, consumer goods and the foodservice industry?

While wanting to protect the country from being overwhelmed by Omicron, China’s adherence to a Zero-COVID policy is resulting in a significant economic downturn. COVID outbreaks in Shanghai, Beijing and many other Chinese cities will impact 2022’s economic growth as consumers and businesses experience rolling lockdowns, leading to a slowdown in domestic and international supply chains. China’s Zero-COVID policy is having a demonstrable impact on consumer-facing industries. Access GlobalData’s new whitepaper, China in 2022: the impact of China’s Zero-COVID lockdowns on economic activity, consumer goods and the foodservice industry, to examine the current situation in Shanghai and other cities in China, to better understand the worst-affected industry sectors, foodservice in particular, and to explore potential growth opportunities as China recovers. The white paper covers:
  • Which multinational companies have been affected?
  • What is the effect of lockdowns on foodservice?
  • What is the effect of lockdowns on Chinese ports?
  • Spotlight on Shanghai: what is the situation there?
  • How have Chinese consumers reacted?
  • How might the Chinese government react?
  • What are the potential growth opportunities?
by GlobalData
Enter your details here to receive your free Whitepaper.

The offer of help came after the media reported that the Ghanaian FDA are trying to clamp down on substandard and fake medicines imported and supplied by Lymens Medical supplies, Osons Chemist and Sarkuff Pharmacy, among others, to health institutions across Ghana.

Ghanaian FDA Chief Executive Officer, Dr Stephen K Opuni, welcomed Chinese support to help fight counterfeit drugs in the country.

According to the official website, Dr Opuni said the origins of these fake drugs from suppliers such as Lymens Medical Supplies were still unidentifiable, despite Lymens assisting police, raising the suspicion of the non-existence of certain companies.

Mr Gao Wendzi, Economic and Commercial counsellor at the Chinese Embassy, pledged to help his Ghanaian counterparts to find the origins of the drugs and help end the illegal trade.

Counterfeit and substandard medicines are a big problem in the developing world with the World Health Organisation estimating that they account for about 30% of all medicines on sale, killing up to 2,000 people daily worldwide.

Earlier this month, the Ghanaian government apprehended three major Ghanaian pharmaceutical companies for supplying substandard and fake drugs to some hospitals and pharmacies across the country.

The companies, including Lymens Medical Supplies Limited and Sarkuff Pharmacy, are suspected off importing unregistered, fake and substandard medicines.

According to the authority, fake Oxytocin and Ergomentrine injections, given to women to control bleeding after child birth, fail to work and could result in death.

The FDA believes the injections were manufactured in China by companies with no addresses.

According to the government website a third company is believed to have registered Ergometrine injection from Ciron Drugs in India with the FDA, however, samples of the product purchased from hospitals countrywide were found to be substandard as they contained no active pharmaceutical ingredients.

The company is also believed to have supplied unregistered and substandard Oxytocin injections manufactured in China by Anhui Medihel Company Limited to hospitals and other health facilities throughout the country.

Hospitals, clinics and pharmacies, as well as the general public, are being advised to take care when purchasing any of these medicines from these companies.


Image: Ghana has experienced and influx of counterfeit and substandard medicines.

Related Companies

Free Whitepaper
img

What is the impact of China’s Zero-COVID lockdowns on economic activity, consumer goods and the foodservice industry?

While wanting to protect the country from being overwhelmed by Omicron, China’s adherence to a Zero-COVID policy is resulting in a significant economic downturn. COVID outbreaks in Shanghai, Beijing and many other Chinese cities will impact 2022’s economic growth as consumers and businesses experience rolling lockdowns, leading to a slowdown in domestic and international supply chains. China’s Zero-COVID policy is having a demonstrable impact on consumer-facing industries. Access GlobalData’s new whitepaper, China in 2022: the impact of China’s Zero-COVID lockdowns on economic activity, consumer goods and the foodservice industry, to examine the current situation in Shanghai and other cities in China, to better understand the worst-affected industry sectors, foodservice in particular, and to explore potential growth opportunities as China recovers. The white paper covers:
  • Which multinational companies have been affected?
  • What is the effect of lockdowns on foodservice?
  • What is the effect of lockdowns on Chinese ports?
  • Spotlight on Shanghai: what is the situation there?
  • How have Chinese consumers reacted?
  • How might the Chinese government react?
  • What are the potential growth opportunities?
by GlobalData
Enter your details here to receive your free Whitepaper.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Pharmaceutical Technology